文献速递细菌感染、耐药与抗菌药物

碳青霉烯耐药肺炎克雷伯菌ST11型:范围综述

Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review.
PubMed 文献 · J Infect Dis · 2026-01-01

本文综述了碳青霉烯耐药肺炎克雷伯菌(CRKP)中ST11型成为优势克隆的关键进化事件,包括获得KPC-2质粒及OmpK35/OmpK36外膜蛋白改变、荚膜切换至KL64型以及获得毒力质粒。文章总结了当前研究进展,讨论了知识空白并提出未来研究方向。

要点

  • ST11 CRKP是亚洲和南美洲部分地区的优势流行型别。
  • KPC-2质粒联合OmpK35/OmpK36改变是耐碳青霉烯的关键机制。
  • 荚膜切换至KL64型及获得毒力质粒促进ST11 CRKP传播。

核心结论

  • ST11 CRKP的成功传播部分归因于获得KPC-2质粒及外膜蛋白改变、荚膜切换至KL64型以及获得毒力质粒等关键进化事件。

研究设计与样本

  • 本文为范围综述,总结ST11 CRKP关键进化事件的研究进展。

主要发现

  • ST11 CRKP是亚洲和南美洲部分地区的优势流行型别。
  • 获得KPC-2质粒联合OmpK35和OmpK36改变导致碳青霉烯耐药。
  • 荚膜切换导致KL64荚膜型出现。
  • 进一步获得常与高毒力ST23谱系相关的毒力质粒。

临床怎么用

  • 应关注ST11 CRKP的进化特征,包括KPC-2质粒、OmpK35/OmpK36改变、KL64荚膜型及毒力质粒。

局限性

  • 本文为综述,指出现有知识空白,未报告原始研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is classified by the World Health Organization as a top-priority pathogen due to its extensive prevalence and dissemination, antimicrobial resistance, and high mortality rates. ST11 CRKP is the most prevalent type in parts of Asia and South America. The success and dissemination of ST11 CRKP can be partly attributed to several key evolutionary events, including the acquisition of the KPC-2 plasmid plus altered outer membrane proteins OmpK35 and OmpK36 that confer carbapenem resistance, the subsequent capsule switching that led to the emergence of the KL64 capsule type, and the further acquisition of virulence plasmids commonly associated with the hypervirulent ST23 lineage. In this review, we summarize the current research advances of these key events, discuss existing knowledge gaps, and propose future directions to understand why ST11 CRKP has emerged as such a dominant and clinically significant clone.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Yang Y, Qin J, Hu Y, et al. Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review. J Infect Dis. 2026. PMID: 41824646. doi:10.1093/infdis/jiaf635

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。